Your browser doesn't support javascript.
loading
Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.
Kantarjian, Hagop; O'Brien, Susan; Jabbour, Elias; Barnes, Gisoo; Pathak, Ashutosh; Cortes, Jorge.
Affiliation
  • Kantarjian H; University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: hkantarjian@mdanderson.org.
  • O'Brien S; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Barnes G; Teva Pharmaceuticals, Frazer, PA.
  • Pathak A; Teva Pharmaceuticals, Frazer, PA.
  • Cortes J; University of Texas MD Anderson Cancer Center, Houston, TX.
Clin Lymphoma Myeloma Leuk ; 15(1): 13-21, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25458084

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Harringtonines / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Harringtonines / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States